𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic liver disease mortality in the United States, 1990–1998

✍ Scribed by Sirenda Vong; Beth P. Bell


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
179 KB
Volume
39
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


In 1998, chronic liver disease (CLD) was the tenth leading cause of death in the U.S. Alcohol and hepatitis C are thought to be important etiologies. However, traditional methods for calculating CLD mortality rates from death certificates may underestimate hepatitis C-related CLD mortality. We studied patterns of CLD deaths reported from 1990 through 1998, using an expanded definition that included death certificates where CLD, viral hepatitis, or CLD-related sequelae were reported as the underlying cause. We calculated overall age-specific and age-adjusted mortality rates, and according to demographic characteristics and recorded causes, and evaluated trends using linear regression modeling. CLD mortality declined 5% overall from 1990 through 1994 (12.1 to 11.6/100,000; P = 0.002), but remained unchanged from 1995 through 1998 (P = 0.366). Decreases were similar for all causes except hepatitis C, for which rates increased 220% from 1993 to 1998 (0.57 to 1.67/100,000). Rates declined in all racial-ethnic groups except American Indians and Alaska Natives (AI/AN), among whom rates were unchanged. Of 30,933 CLD deaths in 1998, 39% were coded as alcohol related, 15% as hepatitis C, 4% as hepatitis B, and 44% had no recorded cause. Age-adjusted rates were higher among males (47.6/100,000) than females (32.2/100,000) and among Hispanics (19.1/100,000) compared with non-Hispanics (10.8/100,000). Rates among AI/AN (28.7/100,000) were more than twice those of African Americans and whites (12.9/100,000 and 11.5/100,000, respectively). In conclusion, 1998 CLD deaths and the proportion attributable to viral hepatitis increased by 23% and 19%, respectively, compared with traditional methods. Mortality declines of the early 1990s were not sustained after 1994. Large disparities in CLD mortality remain, particularly among American Indians and Alaska Natives.


📜 SIMILAR VOLUMES


Association between serum uric acid leve
✍ Anita Afzali; Noel S. Weiss; Edward J. Boyko; George N. Ioannou 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Elevated serum uric acid (UA) levels strongly reflect and may even cause oxidative stress, insulin resistance, and metabolic syndrome, which are risk factors for the progression of liver disease. We sought to determine whether serum UA levels are associated with the development of cirrhosis or the p

The past incidence of hepatitis C virus
✍ Gregory L. Armstrong; Miriam J. Alter; Geraldine M. McQuillan; Harold S. Margoli 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Because chronic liver disease may develop many years after acute hepatitis C virus (HCV) infection, the past incidence of acute infections is a major determinant of the future burden of HCV-associated complications. We estimated past incidence of acute HCV infection using national seroprevalence dat

Rising hospitalization rates for inflamm
✍ Geoffrey C. Nguyen; Anne Tuskey; Themistocles Dassopoulos; Mary L. Harris; Steve 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Background: Recent epidemiological studies suggest that the prevalences of Crohn's disease (CD) and ulcerative colitis (UC) are increasing in the United States. We sought to determine whether nationwide rates of inflammatory bowel disease (IBD) hospitalizations have increased in response to temp